NCT03675386 Reducing Opioid Use for Chronic Pain Patients Following Surgery
| NCT ID | NCT03675386 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Health Network, Toronto |
| Condition | Chronic Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 210 participants |
| Start Date | 2018-10-15 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 210 participants in total. It began in 2018-10-15 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients with chronic pain are often prescribed long-term opioid therapy, despite the serious risks and growing concerns related to opioid use. The Toronto General Hospital has created the world's first multidisciplinary perioperative Transitional Pain Service Program (TPSP) aimed at reducing the incidence and severity of chronic post-surgical pain. The TPSP incorporates a variety of mechanisms and interventions to help patients manage pain and to wean off opioids. The approach consists of: pain education, Acceptance and Commitment Therapy (ACT), and an e-mobile self- management tool to help patients manage chronic pain more effectively. With the TPSP team, the investigators hope to continually assist patients to achieve a balance between the benefits and potential harms of opioid use to promote long-term health and well-being.
Eligibility Criteria
Inclusion Criteria: * ≥ 18 years of age * Taking 10 -- 400 mg of preoperative oral morphine equivalents daily * Any type of surgical procedure, with the exception of those with palliative intent or organ transplantation * Able to read and understand English as posed on the questionnaire surveys prior to informed consent * Must be taking opioids for at least one month prior to their operation * Must have a personal email address for the set-up of the Manage My Pain (MMP) App or online multimedia tool Exclusion Criteria: • Subjects who are undergoing palliative care or procedures, organ transplantation, or prescribed with Methadone/Buprenorphine will be excluded from the trial
Contact & Investigator
Karim Ladha, MD
PRINCIPAL INVESTIGATOR
Toronto General Hospital, University Health Network
Frequently Asked Questions
Who can join the NCT03675386 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03675386 currently recruiting?
Yes, NCT03675386 is actively recruiting participants. Contact the research team at Karim.Ladha@uhn.ca for enrollment information.
Where is the NCT03675386 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT03675386 clinical trial?
NCT03675386 is sponsored by University Health Network, Toronto. The principal investigator is Karim Ladha, MD at Toronto General Hospital, University Health Network. The trial plans to enroll 210 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.